Owner and operator of a biotech company intended for development of treatments for serious diseases. The company's development includes investigation of the modulation of protein-tyro sine sulfation to treat a variety of diseases with unmet medical needs, enabling research companies to get a strategy to generate monoclonal antibodies using antigens containing tyrosine sulfate.